Pages: 240,
Specialty: Endocrinology,
Publisher: Elsevier,
Publication Year: 2009,
Cover: Hardback,
Dimensions: 154.94x231.14x17.78mm
This issue of the "Endocrinology and Metabolism Clinics of North America", devoted to the topic of lipids, provides the most essential updates and new treatments in the field. The following subject matter is addressed: assessment of the effectiveness of advanced lipoprotein testing; rosk scores for prediction of cardiovascular outcomes; lifestyle and dietary approaches to lowering LDC-cholesterol and triglycerides, and raising HDL-cholesterol; and, comparative efficacy and safety of statins, ezetimibe, bile acide binders, and combinations for lowering LDL-C. This book also includes alternative therapies for reducing LDL-C, including intestinal bypass, and new medications such as squalene synthase inhibitors, ApoB antisense oligonucleotides, small interfering RNA's of Apo B and proprotein convertase subtilism kexin 9 (PCSK9); myopathic problems of statins; pharmacologic management of hypertriglyceridemia, including fibric acids, niacin, and fish oils; new treatments for raising LDL cholesterol, lipid management in special patient populations, including pediatric, geriatric, and patients with HIV; and, lipid management in renal failure, hemodialysis, and transplantation.show more
Specialty: Endocrinology,
Publisher: Elsevier,
Publication Year: 2009,
Cover: Hardback,
Dimensions: 154.94x231.14x17.78mm
This issue of the "Endocrinology and Metabolism Clinics of North America", devoted to the topic of lipids, provides the most essential updates and new treatments in the field. The following subject matter is addressed: assessment of the effectiveness of advanced lipoprotein testing; rosk scores for prediction of cardiovascular outcomes; lifestyle and dietary approaches to lowering LDC-cholesterol and triglycerides, and raising HDL-cholesterol; and, comparative efficacy and safety of statins, ezetimibe, bile acide binders, and combinations for lowering LDL-C. This book also includes alternative therapies for reducing LDL-C, including intestinal bypass, and new medications such as squalene synthase inhibitors, ApoB antisense oligonucleotides, small interfering RNA's of Apo B and proprotein convertase subtilism kexin 9 (PCSK9); myopathic problems of statins; pharmacologic management of hypertriglyceridemia, including fibric acids, niacin, and fish oils; new treatments for raising LDL cholesterol, lipid management in special patient populations, including pediatric, geriatric, and patients with HIV; and, lipid management in renal failure, hemodialysis, and transplantation.show more
Spend $70 For Free Shipping
Click the "BUY IT NOW" button to order now! Don't miss out and regret after price increases.
✈ TIME DELIVERY ✈
United States: Usually 10-15 business day.
International: Usually 12-22 business day.
OUR GUARANTEE
At our store, we truly offer the most stunning, trendy highest-quality products in the world.
We will do WHATEVER it takes with outstanding customer service support to assist everyone as we highly value our customer satisfaction with absolute ZERO risk.
We make sure that every customer is 110% satisfied in every aspect with 24/7/365 FAST SUPPORT!
- choosing a selection results in a full page refresh